
In SURMOUNT-ADOLESCENTS, tirzepatide cut BMI 18.5% at 72 weeks vs a 0.5% rise with placebo in adolescents with obesity.
Q In keeping with the national trend, I've noticed that more and more of my school-age and adolescent patients are becoming overweight.






